130 related articles for article (PubMed ID: 30578765)
1. Contrasting effects of microtubule destabilizers versus stabilizers on induction of death in G1 phase of the cell cycle.
Delgado M; Urbaniak A; Chambers TC
Biochem Pharmacol; 2019 Apr; 162():213-223. PubMed ID: 30578765
[TBL] [Abstract][Full Text] [Related]
2. Cell Cycle-Dependent Mechanisms Underlie Vincristine-Induced Death of Primary Acute Lymphoblastic Leukemia Cells.
Kothari A; Hittelman WN; Chambers TC
Cancer Res; 2016 Jun; 76(12):3553-61. PubMed ID: 27197148
[TBL] [Abstract][Full Text] [Related]
3. Primary acute lymphoblastic leukemia cells are susceptible to microtubule depolymerization in G1 and M phases through distinct cell death pathways.
Delgado M; Rainwater RR; Heflin B; Urbaniak A; Butler K; Davidson M; Protacio RM; Baldini G; Edwards A; Reed MR; Raney KD; Chambers TC
J Biol Chem; 2022 Jun; 298(6):101939. PubMed ID: 35436470
[TBL] [Abstract][Full Text] [Related]
4. Microtubules play an essential role in the survival of primary acute lymphoblastic leukemia cells advancing through G1 phase.
Delgado M; Chambers TC
Cell Cycle; 2018; 17(14):1784-1796. PubMed ID: 29995568
[TBL] [Abstract][Full Text] [Related]
5. Eribulin targets a ch-TOG-dependent directed migration of cancer cells.
Chanez B; Gonçalves A; Badache A; Verdier-Pinard P
Oncotarget; 2015 Dec; 6(39):41667-78. PubMed ID: 26497677
[TBL] [Abstract][Full Text] [Related]
6. Toward Discovery of Novel Microtubule Targeting Agents: A SNAP-tag-Based High-Content Screening Assay for the Analysis of Microtubule Dynamics and Cell Cycle Progression.
Berges N; Arens K; Kreusch V; Fischer R; Di Fiore S
SLAS Discov; 2017 Apr; 22(4):387-398. PubMed ID: 28328318
[TBL] [Abstract][Full Text] [Related]
7. Cellular studies reveal mechanistic differences between taccalonolide A and paclitaxel.
Risinger AL; Mooberry SL
Cell Cycle; 2011 Jul; 10(13):2162-71. PubMed ID: 21597323
[TBL] [Abstract][Full Text] [Related]
8. The microtubule targeting agents eribulin and paclitaxel activate similar signaling pathways and induce cell death predominantly in a caspase-independent manner.
Hüsemann LC; Reese A; Radine C; Piekorz RP; Budach W; Sohn D; Jänicke RU
Cell Cycle; 2020 Feb; 19(4):464-478. PubMed ID: 31959066
[TBL] [Abstract][Full Text] [Related]
9. Effects of eribulin, vincristine, paclitaxel and ixabepilone on fast axonal transport and kinesin-1 driven microtubule gliding: implications for chemotherapy-induced peripheral neuropathy.
LaPointe NE; Morfini G; Brady ST; Feinstein SC; Wilson L; Jordan MA
Neurotoxicology; 2013 Jul; 37():231-9. PubMed ID: 23711742
[TBL] [Abstract][Full Text] [Related]
10. Targeting of tubulin polymerization and induction of mitotic blockage by Methyl 2-(5-fluoro-2-hydroxyphenyl)-1H-benzo[d]imidazole-5-carboxylate (MBIC) in human cervical cancer HeLa cell.
Hasanpourghadi M; Karthikeyan C; Pandurangan AK; Looi CY; Trivedi P; Kobayashi K; Tanaka K; Wong WF; Mustafa MR
J Exp Clin Cancer Res; 2016 Mar; 35():58. PubMed ID: 27030360
[TBL] [Abstract][Full Text] [Related]
11. Eribulin Activates the cGAS-STING Pathway via the Cytoplasmic Accumulation of Mitochondrial DNA.
Fermaintt CS; Takahashi-Ruiz L; Liang H; Mooberry SL; Risinger AL
Mol Pharmacol; 2021 Oct; 100(4):309-318. PubMed ID: 34312217
[TBL] [Abstract][Full Text] [Related]
12. Microtubule-targeting agents are clinically successful due to both mitotic and interphase impairment of microtubule function.
Field JJ; Kanakkanthara A; Miller JH
Bioorg Med Chem; 2014 Sep; 22(18):5050-9. PubMed ID: 24650703
[TBL] [Abstract][Full Text] [Related]
13. Arsenic trioxide produces polymerization of microtubules and mitotic arrest before apoptosis in human tumor cell lines.
Ling YH; Jiang JD; Holland JF; Perez-Soler R
Mol Pharmacol; 2002 Sep; 62(3):529-38. PubMed ID: 12181429
[TBL] [Abstract][Full Text] [Related]
14. Leiodermatolide, a novel marine natural product, has potent cytotoxic and antimitotic activity against cancer cells, appears to affect microtubule dynamics, and exhibits antitumor activity.
Guzmán EA; Xu Q; Pitts TP; Mitsuhashi KO; Baker C; Linley PA; Oestreicher J; Tendyke K; Winder PL; Suh EM; Wright AE
Int J Cancer; 2016 Nov; 139(9):2116-26. PubMed ID: 27376928
[TBL] [Abstract][Full Text] [Related]
15. Microtubule Targeting Agents as Cancer Chemotherapeutics: An Overview of Molecular Hybrids as Stabilizing and Destabilizing Agents.
Tangutur AD; Kumar D; Krishna KV; Kantevari S
Curr Top Med Chem; 2017; 17(22):2523-2537. PubMed ID: 28056738
[TBL] [Abstract][Full Text] [Related]
16. Novel synthetic pharmacophores inducing a stabilization of cellular microtubules.
Martinez A; Soleilhac E; Barette C; Prudent R; Gozzi GJ; Vassal-Stermann E; Pillet C; Di Pietro A; Fauvarque MO; Lafanechere L
Curr Cancer Drug Targets; 2015; 15(1):2-13. PubMed ID: 25543663
[TBL] [Abstract][Full Text] [Related]
17. BCL-W is a regulator of microtubule inhibitor-induced mitotic cell death.
Huang S; Tang R; Poon RY
Oncotarget; 2016 Jun; 7(25):38718-38730. PubMed ID: 27231850
[TBL] [Abstract][Full Text] [Related]
18. Breast Cancer Cell Lines Exhibit Differential Sensitivities to Microtubule-targeting Drugs Independent of Doubling Time.
Risinger AL; Dybdal-Hargreaves NF; Mooberry SL
Anticancer Res; 2015 Nov; 35(11):5845-50. PubMed ID: 26504006
[TBL] [Abstract][Full Text] [Related]
19. G(1) and G(2) cell-cycle arrest following microtubule depolymerization in human breast cancer cells.
Blajeski AL; Phan VA; Kottke TJ; Kaufmann SH
J Clin Invest; 2002 Jul; 110(1):91-9. PubMed ID: 12093892
[TBL] [Abstract][Full Text] [Related]
20. Induction of apoptosis accompanying with G(1) phase arrest and microtubule disassembly in human hepatoma cells by jaspolide B, a new isomalabaricane-type triterpene.
Wei SY; Li M; Tang SA; Sun W; Xu B; Cui JR; Lin WH
Cancer Lett; 2008 Apr; 262(1):114-22. PubMed ID: 18191890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
